Alexandre Hertig

Prof. Alexandre Hertig


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2020 in Toxins
Verified
Journal Article
Open access
PDF file
AJAdrien JOSEPH
Adrien JOSEPH
ACAurélie Cointe
Aurélie Cointe
PKPatricia Mariani Kurkdjian
Patricia Mariani Kurkdjian
CRCédric Rafat
Cédric Rafat
AHAlexandre Hertig
Alexandre Hertig
The severity of human infection by one of the many Shiga toxin-producing Escherichia coli (STEC) is determined by a number of factors: the bacterial genome, the capacity of human societies to prevent foodborne epidemics, the medical condition of infected patients (in particular their hydration status, often compromised by severe diarrhea), and by our capacity to devise new therapeutic approaches, most specifically to combat the bacterial virulence factors, as opposed to our current strategies that essentially aim to palliate organ deficiencies. The last major outbreak in 2011 in Germany, which killed more than 50 people in Europe, was evidence that an effective treatment was still lacking. Herein, we review the current knowledge of STEC virulence, how societies organize the prevention of human disease, and how physicians treat (and, hopefully, will treat) its potentially fatal complications. In particular, we focus on STEC-induced hemolytic and uremic syndrome (HUS), where the intrusion of toxins inside endothelial cells results in massive cell death, activation of the coagulation within capillaries, and eventually organ failure.

20 July 2020 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
DLDavid Legouis
David Legouis
SRSven-Erick Ricksten
Sven-Erick Ricksten
AFAnna Faivre
Anna Faivre
TVThomas Verissimo
Thomas Verissimo
KGKarim Gariani
Karim Gariani
SSSophie de Seigneux
Sophie de Seigneux

1 January 2016 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
YXYi-Chun Xu-Dubois
Yi-Chun Xu-Dubois
JPJulie Peltier
Julie Peltier
IBIsabelle Brocheriou
Isabelle Brocheriou
CSCaroline Suberbielle-Boissel
Caroline Suberbielle-Boissel
ADArjang Djamali
Arjang Djamali
AHAlexandre Hertig
Alexandre Hertig
Antibody-mediated rejection (ABMR) is a leading cause of allograft loss. Treatment efficacy depends on accurate diagnosis at an early stage. However, sensitive and reliable markers of antibody-endothelium interaction during ABMR are not available for routine use. Using immunohistochemistry, we retrospectively studied the diagnostic value of three markers of endothelial-to-mesenchymal transition (EndMT), fascin1, vimentin, and heat shock protein 47, for ABMR in 53 renal transplant biopsy specimens, including 20 ABMR specimens, 24 cell-mediated rejection specimens, and nine normal grafts. We validated our results in an independent set of 74 unselected biopsy specimens. Endothelial cells of the peritubular capillaries in grafts with ABMR expressed fascin1, vimentin, and heat shock protein 47 strongly, whereas those from normal renal grafts did not. The level of EndMT marker expression was significantly associated with current ABMR criteria, including capillaritis, glomerulitis, peritubular capillary C4d deposition, and donor-specific antibodies. These markers allowed us to identify C4d-negative ABMR and to predict late occurrence of disease. EndMT markers were more specific than capillaritis for the diagnosis and prognosis of ABMR and predicted late (up to 4 years after biopsy) renal graft dysfunction and proteinuria. In the independent set of 74 renal graft biopsy specimens, the EndMT markers for the diagnosis of ABMR had a sensitivity of 100% and a specificity of 85%. Fascin1 expression in peritubular capillaries was also induced in a rat model of ABMR. In conclusion, EndMT markers are a sensitive and reliable diagnostic tool for detecting endothelial activation during ABMR and predicting late loss of allograft function.

11 January 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
YBYohan Bignon
Yohan Bignon
ARAnna Rinaldi
Anna Rinaldi
ZNZahia Nadour
Zahia Nadour
VPVirginie Poindessous
Virginie Poindessous
INIvan Nemazanyy
Ivan Nemazanyy
NPNicolas Pallet
Nicolas Pallet
The biosynthetic routes leading to de novo nicotinamide adenine dinucleotide (NAD + ) production are involved in acute kidney injury (AKI), with a critical role for quinolinate phosphoribosyl transferase (QPRT), a bottleneck enzyme of de novo NAD + biosynthesis. The molecular mechanisms determining reduced QPRT in AKI, and the role of impaired NAD + biosynthesis in the progression to chronic kidney disease (CKD), are unknown. We demonstrate that a high urinary quinolinate-to-tryptophan ratio, an indirect indicator of impaired QPRT activity and reduced de novo NAD + biosynthesis in the kidney, is a clinically applicable early marker of AKI after cardiac surgery and is predictive of progression to CKD in kidney transplant recipients. We also provide evidence that the endoplasmic reticulum (ER) stress response may impair de novo NAD + biosynthesis by repressing QPRT transcription. In conclusion, NAD + biosynthesis impairment is an early event in AKI embedded with the ER stress response, and persistent reduction of QPRT expression is associated with AKI to CKD progression. This finding may lead to identification of noninvasive metabolic biomarkers of kidney injury with prognostic and therapeutic implications.

1 September 2018 in Placenta
Verified
Journal Article
Closed access
NBNadia Berkane
Nadia Berkane
PLPhilippe Liere
Philippe Liere
GLGuillaume Lefevre
Guillaume Lefevre
NANadia Alfaidy
Nadia Alfaidy
RNRoland Abi Nahed
Roland Abi Nahed
AHAlexandre Hertig
Alexandre Hertig

19 June 2018 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
ABAurélien Bataille
Aurélien Bataille
PGPierre Galichon
Pierre Galichon
NCNadjim Chelghoum
Nadjim Chelghoum
BOBadreddine Mohand Oumoussa
Badreddine Mohand Oumoussa
MZMarie-Julia Ziliotis
Marie-Julia Ziliotis
AHAlexandre Hertig
Alexandre Hertig
Background/Aims: Fatty acid oxidation (FAO), the main source of energy produced by tubular epithelial cells in the kidney, was found to be defective in tubulo-interstitial samples dissected out in kidney biopsies from patients with chronic kidney disease (CKD). Experimental data indicated that this decrease was a strong determinant of renal fibrogenesis, hence a focus for therapeutic interventions. Nevertheless, whether persistently differentiated renal tubules, surviving in a pro-fibrotic environment, also suffer from a decrease in FAO, is currently unknown. Methods: To address this question, we isolated proximal tubules captured ex vivo on the basis of the expression of an intact brush border antigen (Prominin-1) in C57BL6/J mice subjected to a controlled, two-hit model of renal fibrosis (reversible ischemic acute kidney injury (AKI) or sham surgery, followed by angiotensin 2 administration). A transcriptomic high throughput sequencing was performed on total mRNA from these cells, and on whole kidneys. Results: In contrast to mice subjected to sham surgery, mice with a history of AKI displayed histologically more renal fibrosis when exposed to angiotensin 2. High throughput RNA sequencing, principal component analysis and clustering showed marked consistency within experimental groups. As expected, FAO transcripts were decreased in whole fibrotic kidneys. Surprisingly, however, up- rather than down-regulation of metabolic pathways (oxidative phosphorylation, fatty acid metabolism, glycolysis, and PPAR signalling pathway) was a hallmark of the differentiated tubules captured from fibrotic kidneys. Immunofluorescence co-staining analysis confirmed that the expression of FAO enzymes was dependent of tubular trophicity. Conclusions: These data suggest that in differentiated proximal tubules energetic hyperactivity is promoted concurrently with organ fibrogenesis.